BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 22648868)

  • 1. Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon.
    Chiu YE; Drolet BA; Blei F; Carcao M; Fangusaro J; Kelly ME; Krol A; Lofgren S; Mancini AJ; Metry DW; Recht M; Silverman RA; Tom WL; Pope E
    Pediatr Blood Cancer; 2012 Nov; 59(5):934-8. PubMed ID: 22648868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon.
    Wang Z; Li K; Dong K; Xiao X; Zheng S
    Pediatr Blood Cancer; 2014 Aug; 61(8):1518-9. PubMed ID: 24482015
    [No Abstract]   [Full Text] [Related]  

  • 3. Low dose sirolimus treatment for refractory tufted angioma and congenital kaposiform hemangioendothelioma, both with Kasabach-Merritt phenomenon.
    Mariani LG; Schmitt IR; Garcia CD; Kiszewski AE
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27810. PubMed ID: 31087627
    [No Abstract]   [Full Text] [Related]  

  • 4. Tacrolimus ointment for the treatment of superficial kaposiform hemangioendothelioma and tufted angioma.
    Zhang X; Yang K; Chen S; Ji Y
    J Dermatol; 2019 Oct; 46(10):898-901. PubMed ID: 31373046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical management of tumors associated with Kasabach-Merritt phenomenon: an expert survey.
    Tlougan BE; Lee MT; Drolet BA; Frieden IJ; Adams DM; Garzon MC
    J Pediatr Hematol Oncol; 2013 Nov; 35(8):618-22. PubMed ID: 23774156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma.
    Wang H; Guo X; Duan Y; Zheng B; Gao Y
    Pediatr Dermatol; 2018 Sep; 35(5):635-638. PubMed ID: 29999213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
    Cashell J; Smink GM; Helm K; Xavier F
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27305. PubMed ID: 30070028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus therapy for children with problematic kaposiform haemangioendothelioma and tufted angioma.
    Tasani M; Ancliff P; Glover M
    Br J Dermatol; 2017 Dec; 177(6):e344-e346. PubMed ID: 28485019
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of Kaposiform hemangioendothelioma with everolimus.
    Uno T; Ito S; Nakazawa A; Miyazaki O; Mori T; Terashima K
    Pediatr Blood Cancer; 2015 Mar; 62(3):536-8. PubMed ID: 25306933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Corticosteroid and Vincristine in Treating Kaposiform Hemangioendothelioma and Tufted Angioma: A Systematic Review and Meta-Analysis.
    Yao W; Li K; Wang Z; Pei J; Liu X; Zheng S; Dong K
    Eur J Pediatr Surg; 2019 Oct; 29(5):401-407. PubMed ID: 30372769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasonography and magnetic resonance imaging features of kaposiform hemangioendothelioma and tufted angioma.
    Gong X; Ying H; Zhang Z; Wang L; Li J; Ding A; Zhou L; Lin X; Xiong P
    J Dermatol; 2019 Oct; 46(10):835-842. PubMed ID: 31373042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment.
    Hermans DJ; van Beynum IM; van der Vijver RJ; Kool LJ; de Blaauw I; van der Vleuten CJ
    J Pediatr Hematol Oncol; 2011 May; 33(4):e171-3. PubMed ID: 21516018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Image Gallery: Kaposiform haemangioendothelioma.
    Moscarella E; Ametrano O; Diplomatico M; De Chiara C; Capasso M; Errico ME; Picciocchi R
    Br J Dermatol; 2017 Jun; 176(6):e124. PubMed ID: 28581217
    [No Abstract]   [Full Text] [Related]  

  • 14. NEWBORNS WITH KASABACH-MERRITT PHENOMENON-ASSOCIATED KAPOSIFORM HEMANGIOENDOTHELIOMA: A REPORT OF 6 CASES.
    Benzar IM; Rebenkov SO; Levytskyi AF; Fedoniuk LY; Fomina LV; Sas LM; Stravskyy TY
    Wiad Lek; 2020; 73(8):1785-1789. PubMed ID: 33055352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Kasabach-Merritt phenomenon following vaccination: More than a coincidence?
    Ji Y; Chen S; Yang K; Xia C; Peng S
    J Dermatol; 2018 Oct; 45(10):1203-1206. PubMed ID: 30118141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with vincristine and ticlopidine.
    Barabash-Neila R; García-Rodríguez E; Bernabeu-Wittel J; Bueno-Rodríguez I; Ramírez-Villar G; López-Gutierrez JC
    Indian J Pediatr; 2012 Oct; 79(10):1386-7. PubMed ID: 22161581
    [No Abstract]   [Full Text] [Related]  

  • 17. Kaposiform hemangioendothelioma and tufted angioma - (epi)genetic analysis including genome-wide methylation profiling.
    Ten Broek RW; Koelsche C; Eijkelenboom A; Mentzel T; Creytens D; Vokuhl C; van Gorp JM; Versleijen-Jonkers YM; van der Vleuten CJ; Kemmeren P; van de Geer E; von Deimling A; Flucke U
    Ann Diagn Pathol; 2020 Feb; 44():151434. PubMed ID: 31887709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identical Presentation of Scapular Osteolysis in Two Patients with Thoracic Kaposiform Hemangioendothelioma.
    Alonso Arroyo V; Lopez-Gutierrez JC; Martinez R; Fernandez-Pineda I
    Pediatr Dermatol; 2017 May; 34(3):e146-e149. PubMed ID: 28382716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Propranolol Treatment of a Kaposiform Hemangioendothelioma Apparently Resistant to Propranolol.
    Filippi L; Tamburini A; Berti E; Perrone A; Defilippi C; Favre C; Calvani M; Della Bona ML; la Marca G; Donzelli G
    Pediatr Blood Cancer; 2016 Jul; 63(7):1290-2. PubMed ID: 27100060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposiform hemangioendothelioma and tufted angioma: two entities of the same clinicopathological spectrum.
    Nieto-Benito LM; Huerta-Aragonés J; Parra-Blanco V; Campos-Domínguez M
    An Bras Dermatol; 2023; 98(3):391-394. PubMed ID: 36604299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.